Medicyte GmbH Benefits From Multi-Million Euro EU Grant VascuBone

01-Apr-2010 - Germany

Medicyte has been elected partner in the VascuBone project, in which 15 European partners from industry and academic institutions work on practical, yet individual solutions in bone regenerative medicine. The VascuBone project is supported by a 12 million Euro FP7 grant from the European Union starting in 2010 to 2015.

Initiator and organizer of VascuBone is Prof. Dr. Heike Walles, recently appointed head of the Department for Regenerative Medicine at University of Würzburg. The goal of VascuBone is to develop a 'tool box' for bone regeneration, which fulfils basic requirements and is freely combinable with what is needed in the respective patient's situation. Among others, the tool box will include a variation of biocompatible biomaterials and cell types.

With the company's expertise and proprietary technologies, Medicyte's contribution will be to support in developing and supplying cells and cell factors for the VascuBone toolbox. The 15 project partners include Fraunhofer Institute, Johnson & Johnson Medical and Royal Institute of Technology, Sweden.

Other news from the department business & finance

Most read news

More news from our other portals

Last viewed contents

Kill the cancer, not the patient: New toxicity testing approach could make chemo drugs safer - National Cancer Institute grants $1M to test 3 chemo drugs

Pioneering discovery of an odor-detecting receptor enhancer

Pioneering discovery of an odor-detecting receptor enhancer

Modified crops reveal hidden cost of resistance

MorphoSys Announces Second Clinical Milestone in Therapeutic Antibody Program - First HuCAL-based Antibody to Enter Clinical Trial in Second Indication

Viruses on the run - ETH Zurich Professor Ari Helenius awarded Benoist Prize

Viruses on the run - ETH Zurich Professor Ari Helenius awarded Benoist Prize

New approach in the treatment of non-alcoholic fatty liver disease - Resistant starch, such as that found in green bananas, may play an important role in treatment of non-alcoholic fatty liver disease in the future

New approach in the treatment of non-alcoholic fatty liver disease - Resistant starch, such as that found in green bananas, may play an important role in treatment of non-alcoholic fatty liver disease in the future

New model could revolutionise the treatment of autoimmune disease as well as vaccine development - Paradigm shift in immunology: 'Adaptive Tolerance' balances autoimmune reaction

New model could revolutionise the treatment of autoimmune disease as well as vaccine development - Paradigm shift in immunology: 'Adaptive Tolerance' balances autoimmune reaction

Successful Outcome from European Clinical Pharmacokinetic Study Comparing SUBA-Itraconazole with Sporanox - HalcyGen to begin Marketing Authorisation Application for Regulators in Europe

Evotec Receives a Milestone Payment as Part of its Discovery Alliance with Boehringer Ingelheim

UF study strengthens concerns about long-term use of certain painkillers

Scientists at Almac and Queen’s University Belfast discover novel approach to treat cancer patients.

Restoring chemotherapy sensitivity by boosting microRNA levels

Restoring chemotherapy sensitivity by boosting microRNA levels